Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

키워드

참고문헌 (33)

1. Liu C, "Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children", Clin Infect Dis, 52, pp.e18~e55 (2011)
2. Kalil AC, "Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis", JAMA, 312, pp.1552~1564 (2014)
3. Neely MN, "Are vancomycin trough concentrations adequate for optimal dosing?", Antimicrob Agents Chemother, 58, pp.309~316 (2014)
4. Zelenitsky S, "Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock", Int J Antimicrob Agents, 41, pp.255~260 (2013)
5. Cavalcanti AB, "Teicoplanin versus vancomycin for proven or suspected infection", Cochrane Database Syst Rev, pp.CD007022~ (2010)
6. Yoon YK, "Multicenter prospective observational study of the comparative efficacy and safety of vancomycin versus teicoplanin in patients with health", Antimicrob Agents Chemother, 58, pp.317~324 (2014)
7. Karlowsky JA, "Telavancin: mechanisms of action, in vitro activity, and mechanisms of resistance", Clin Infect Dis, 61(Suppl 2), pp.S58~S68 (2015)
8. Stryjewski ME, "A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study", BMC Infect Dis, 14, pp.289~ (2014)
9. "A phase 3 telavancin Staphylococcus aureus (S. Aureus) bacteremia trial"[URL]
10. Fowler VG Jr, "Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus", N Engl J Med, 355, pp.653~665 (2006)
11. Carpenter CF, "Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens", Clin Infect Dis, 38, pp.994~1000 (2004)
12. Moore CL, "Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study", Clin Infect Dis, 54, pp.51~58 (2012)
13. Murray KP, "Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg", L: a matched cohort study, 2013, pp.56, 1562~1569
14. Saravolatz LD, "Ceftaroline: a novel cephalosporin with activity against methicillin-resistant Staphylococcus aureus", Clin Infect Dis, 52, pp.1156~1163 (2011)
15. Otero LH, "How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function", Proc Natl Acad Sci U S A, 110, pp.16808~16813 (2013)
16. Espedido BA, "Ceftaroline fosamil salvage therapy: an option for reduced-vancomycin-susceptible MRSA bacteraemia", J Antimicrob Chemother, 70, pp.797~801 (2015)
17. Vazquez JA, "Ceftaroline fosamil for the treatment of Staphylococcus aureus bacteremia secondary to acute bacterial skin and skin structure infections or community-acquired bacterial pneumonia", Infect Dis Clin Pract (Baltim Md), 23, pp.39~43 (2015)
18. Casapao AM, "Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy", Antimicrob Agents Chemother, 58, pp.2541~2546 (2014)
19. Moellering RC, "Linezolid: the first oxazolidinone antimicrobial", Ann Intern Med, 138, pp.135~142 (2003)
20. Stevens DL, "Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics", Clin Infect Dis, 42, pp.729~730 (2006)
21. Jang HC, "Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem", Clin Infect Dis, 49, pp.395~401 (2009)
22. Wilcox MH, "Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study", Clin Infect Dis, 48, pp.203~212 (2009)
23. Park HJ, "Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia", J Infect, 65, pp.505~512 (2012)
24. Sánchez García M, "Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit", JAMA, 303, pp.2260~2264 (2010)
25. Rybak JM, "Early experience with tedizolid:clinical efficacy, pharmacodynamics, and resistance", Pharmacotherapy, 34, pp.1198~1208 (2014)
26. Chan LC, "Comparative efficacies of tedizolid phosphate, vancomycin, and daptomycin in a rabbit model of methicillin-resistant Staphylococcus aureus endocarditis", Antimicrob Agents Chemother, 59, pp.3252~3256 (2015)
27. Stein GE, "Tigecycline: an update", Diagn Microbiol Infect Dis, 75, pp.331~336 (2013)
28. Gardiner D, "Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials", Clin Infect Dis, 50, pp.229~238 (2010)
29. Ramirez J, "Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia", Antimicrob Agents Chemother, 57, pp.1756~1762 (2013)
30. Dilworth TJ, "beta-Lactams enhance vancomycin activity against methicillin-resistant Staphylococcus aureus bacteremia compared to vancomycin alone", Antimicrob Agents Chemother, 58, pp.102~109 (2014)
31. Davis JS, "Australasian Society for Infectious Diseases Clinical Research Network. Combination of vancomycin and beta-lactam therapy for methicillin-resistant Staphylococcus aureus bacteremia: a pilot multicenter randomized controlled trial", Clin Infect Dis, 62, pp.173~180 (2016)
32. Chambers HF, "Daptomycin- β-lactam combinations in a rabbit model of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus endocarditis", Antimicrob Agents Chemother, 60, pp.3976~3979 (2016)
33. Sakoulas G, "Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline", Clin Ther, 36, pp.1317~1333 (2014)

관련 논문AI추천